81_FR_48568 81 FR 48426 - Health Center Program

81 FR 48426 - Health Center Program

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration

Federal Register Volume 81, Issue 142 (July 25, 2016)

Page Range48426-48426
FR Document2016-17497

The Bureau of Primary Health Care (BPHC) is awarding funds to health centers transitioning to value-based models of care, improving the use of information in decision making, and increasing engagement in delivery system transformation.

Federal Register, Volume 81 Issue 142 (Monday, July 25, 2016)
[Federal Register Volume 81, Number 142 (Monday, July 25, 2016)]
[Notices]
[Page 48426]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-17497]



[[Page 48426]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Health Center Program

AGENCY: Health Resources and Services Administration, HHS.

ACTION: Notice of class deviations from the requirements for 
competition and application period for the health center program.

-----------------------------------------------------------------------

SUMMARY: The Bureau of Primary Health Care (BPHC) is awarding funds to 
health centers transitioning to value-based models of care, improving 
the use of information in decision making, and increasing engagement in 
delivery system transformation.

SUPPLEMENTARY INFORMATION: 
    Intended Recipient of the Award: Approximately 1,380 Health Center 
Program award recipients.
    Amount of Competitive Awards: Approximately $90 million will be 
awarded in FY 2016 through a one-time supplement.
    Period of Supplemental Funding: Anticipated 12 month project period 
is September 1, 2016 through August 31, 2017.
    CFDA Number: 93.224.

    Authority:  Section 330 of the Public Health Service Act, as 
amended (42 U.S.C. 254b, as amended).

    Justification: Targeting the Nation's neediest populations and 
geographic areas, the Health Center Program supports more than 1,300 
health centers that operate over 9,000 service delivery sites in every 
state, the District of Columbia, Puerto Rico, the Virgin Islands, and 
the Pacific Basin. Nearly 23 million patients received comprehensive, 
culturally competent, quality primary health care services through the 
Health Center Program award recipients in 2014.
    The fiscal year (FY) 2016 Health Center Program Delivery System 
Health Information Investment (DSHII) funding will provide formula-
based, one-time support for the purchase of health information 
technology (health IT) enhancements to accelerate health centers' 
transition to value-based models of care, improve efforts to share and 
use information to support better decisions, and increase engagement in 
delivery system transformation efforts. Grant funds will help health 
centers make strategic investments to enhance their health IT, 
implement new clinical and administrative workflows, develop new 
reports, and better prepare providers and staff to use health IT and 
data to achieve the quality, cost, and patient-centered goals of 
delivery system reforms. In addition, health centers that do not 
currently have a certified electronic health record (EHR) at all sites 
and in use by all providers must propose at a minimum to use DSHII 
funding to initiate and/or increase the number of sites and providers 
using a certified EHR. The investments will help health centers improve 
the quality and safety of services provided to the nation's most 
vulnerable populations.

FOR FURTHER INFORMATION CONTACT: Olivia Shockey, Expansion Division 
Director, Office of Policy and Program Development, Bureau of Primary 
Health Care, Health Resources and Services Administration at 301-443-
9282 or [email protected].

    Dated: July 18, 2016.
James Macrae,
Acting Administrator.
[FR Doc. 2016-17497 Filed 7-22-16; 8:45 am]
 BILLING CODE 4165-15-P



                                                  48426                           Federal Register / Vol. 81, No. 142 / Monday, July 25, 2016 / Notices

                                                  DEPARTMENT OF HEALTH AND                                 data to achieve the quality, cost, and                   Independent of its a-Toxin Gene.’’
                                                  HUMAN SERVICES                                           patient-centered goals of delivery                       HGT 20:751–758, July 2009 (hereafter
                                                                                                           system reforms. In addition, health                      referred to as ‘‘HGT 2009’’) (Retracted
                                                  Health Resources and Services                            centers that do not currently have a                     03/2010).
                                                  Administration                                           certified electronic health record (EHR)              • Li, Z., Fallon, J., Mandeli, J., Wetmur,
                                                                                                           at all sites and in use by all providers                 J., & Woo, S.L.C. ‘‘Oncopathic
                                                  Health Center Program                                    must propose at a minimum to use                         Bacteriotherapy with Engineered C.
                                                  AGENCY:  Health Resources and Services                   DSHII funding to initiate and/or                         perfringens Spores is Superior and
                                                  Administration, HHS.                                     increase the number of sites and                         Complementary to Gemcitabine
                                                  ACTION: Notice of class deviations from
                                                                                                           providers using a certified EHR. The                     Treatment in an Orthotopic Murine
                                                  the requirements for competition and                     investments will help health centers                     Model of Pancreatic Cancer.’’
                                                                                                           improve the quality and safety of                        Submitted for publication in Can. Res.
                                                  application period for the health center
                                                                                                           services provided to the nation’s most                   (hereafter referred to as the ‘‘Can. Res.
                                                  program.
                                                                                                           vulnerable populations.                                  Manuscript 2009’’).
                                                  SUMMARY:   The Bureau of Primary Health                  FOR FURTHER INFORMATION CONTACT:                      • Li, Z., Fallon, J., Mandeli, J., Wetmur,
                                                  Care (BPHC) is awarding funds to health                  Olivia Shockey, Expansion Division                       J., & Woo, S.L.C. ‘‘Oncopathic
                                                  centers transitioning to value-based                     Director, Office of Policy and Program                   Bacteriotherapy with Cp/plc-/sod-/
                                                  models of care, improving the use of                     Development, Bureau of Primary Health                    PVL is Complementary to
                                                  information in decision making, and                      Care, Health Resources and Services                      Gemcitabine Treatment for Pancreatic
                                                  increasing engagement in delivery                        Administration at 301–443–9282 or                        Cancer in Mice.’’ Presented at the
                                                  system transformation.                                   oshockey@hrsa.gov.                                       12th Annual Meeting of the American
                                                  SUPPLEMENTARY INFORMATION:                                 Dated: July 18, 2016.
                                                                                                                                                                    Society of Gene Therapy, May 27–30,
                                                    Intended Recipient of the Award:                                                                                2009.
                                                                                                           James Macrae,
                                                  Approximately 1,380 Health Center                                                                              • R21 CA120017–02
                                                  Program award recipients.
                                                                                                           Acting Administrator.                                 • R21 CA120017 Final Progress Report
                                                    Amount of Competitive Awards:
                                                                                                           [FR Doc. 2016–17497 Filed 7–22–16; 8:45 am]           • R01 CA130897–01
                                                                                                           BILLING CODE 4165–15–P                                • R01 CA130897–01 A1
                                                  Approximately $90 million will be
                                                                                                                                                                 • R01 CA130897–01 A2
                                                  awarded in FY 2016 through a one-time                                                                          • R01 CA130897–01 A2 Supplemental
                                                  supplement.                                              DEPARTMENT OF HEALTH AND                                 Material
                                                    Period of Supplemental Funding:                                                                              • R01 CA148697–01
                                                                                                           HUMAN SERVICES
                                                  Anticipated 12 month project period is
                                                                                                                                                                    The JNCI 2008 and HGT 2009 papers
                                                  September 1, 2016 through August 31,                     Office of the Secretary                               were retracted, and the Can. Res.
                                                  2017.
                                                    CFDA Number: 93.224.                                                                                         Manuscript 2009 was withdrawn.
                                                                                                           Findings of Research Misconduct                          ORI found that the Respondent
                                                    Authority: Section 330 of the Public                   AGENCY:   Office of the Secretary, HHS.               intentionally, knowingly, and recklessly
                                                  Health Service Act, as amended (42 U.S.C.                                                                      engaged in research misconduct by
                                                  254b, as amended).                                       ACTION:   Notice.
                                                                                                                                                                 falsely claiming to have generated
                                                     Justification: Targeting the Nation’s                 SUMMARY:   Notice is hereby given that                recombinant Clostridium perfringens
                                                  neediest populations and geographic                      the Office of Research Integrity (ORI)                (Cp) strains, Cp/sod-, Cp/sod-/PVL, and
                                                  areas, the Health Center Program                         has taken final action in the following               Cp/plc-/sod-/PVL, to depict the effects
                                                  supports more than 1,300 health centers                  case:                                                 of recombinant Cp strains on their
                                                  that operate over 9,000 service delivery                   Zhiyu Li, Ph.D., Mount Sinai School                 ability to destroy cancer cells in a
                                                  sites in every state, the District of                    of Medicine: Based upon the evidence                  murine model, when these bacterial
                                                  Columbia, Puerto Rico, the Virgin                        and findings of an investigation report               strains were not produced nor the data
                                                  Islands, and the Pacific Basin. Nearly 23                by the Mount Sinai School of Medicine                 derived from them, and by falsifying
                                                  million patients received                                (MSSM) and additional analysis                        histopathological data reported in fifty-
                                                  comprehensive, culturally competent,                     conducted by ORI in its oversight                     seven (57) images in two (2) published
                                                  quality primary health care services                     review, ORI found that Dr. Zhiyu Li,                  papers, one (1) submitted manuscript,
                                                  through the Health Center Program                        former Postdoctoral Fellow, MSSM,                     two (2) poster presentations, and seven
                                                  award recipients in 2014.                                engaged in research misconduct in                     (7) of Respondent’s supervisor’s grant
                                                     The fiscal year (FY) 2016 Health                      research that was supported by National               applications and fabricating the
                                                  Center Program Delivery System Health                    Cancer Institute (NCI), National                      corresponding nineteen (19) summary
                                                  Information Investment (DSHII) funding                   Institutes of Health (NIH), grant R21                 bar graphs that were based on those
                                                  will provide formula-based, one-time                     CA120017. ORI found that falsified and/               false images.
                                                  support for the purchase of health                       or fabricated data were included in the                  Specifically, Respondent trimmed and
                                                  information technology (health IT)                       following published papers, submitted                 used portions of Figure 6 (right panel)
                                                  enhancements to accelerate health                        manuscript, poster presentation, and                  of a draft R21 CA120017–01 grant
                                                  centers’ transition to value-based                       grant applications:                                   application, representing an image of
                                                  models of care, improve efforts to share                 • Li, Z., Fallon, J., Mandeli, J., Wetmur,            liver tumor two (2) days after injection
                                                  and use information to support better                      J., & Woo, S.L.C. ‘‘A Genetically                   of Cp/plc- bacteria, to represent
                                                  decisions, and increase engagement in                      Enhanced Anaerobic Bacterium for                    unrelated results from different
mstockstill on DSK3G9T082PROD with NOTICES




                                                  delivery system transformation efforts.                    Oncopathic Therapy of Pancreatic                    experiments in:
                                                  Grant funds will help health centers                       Cancer.’’ JNCI 100(19):1389–1400,                   • Figures 5D and 7C (left panel), grant
                                                  make strategic investments to enhance                      October 2008 (hereafter referred to as                 R21 CA120017 Final Progress Report
                                                  their health IT, implement new clinical                    ‘‘JNCI 2008’’) (Retracted 02/2010).                 • Figure 6A, grant R01 CA130897–01
                                                  and administrative workflows, develop                    • Li, Z., Fallon, J., Mandeli, J., Wetmur,            • Figures 9D and 17A (top left, middle,
                                                  new reports, and better prepare                            J., & Woo, S.L.C. ‘‘The Oncopathic                     and right panels and bottom left
                                                  providers and staff to use health IT and                   Potency of Clostridium perfringens is                  panel), grant R01 CA130897–01 A1


                                             VerDate Sep<11>2014   18:27 Jul 22, 2016   Jkt 238001   PO 00000   Frm 00052   Fmt 4703   Sfmt 4703   E:\FR\FM\25JYN1.SGM   25JYN1



Document Created: 2016-07-23 02:00:48
Document Modified: 2016-07-23 02:00:48
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice of class deviations from the requirements for competition and application period for the health center program.
ContactOlivia Shockey, Expansion Division Director, Office of Policy and Program Development, Bureau of Primary Health Care, Health Resources and Services Administration at 301-443- 9282 or [email protected]
FR Citation81 FR 48426 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR